Use of Combination Proteomic Analysis to Demonstrate Molecular Similarity of Head and Neck Squamous Cell Carcinoma Arising From Different Subsites
Weinberger et al.
Arch Otolaryngol Head Neck Surg 2009;135:694-703.
ABSTRACT
| FULL TEXT
Prospective Study on Neck Dissection after Primary Chemoradiation Therapy in Stage IV Pharyngeal Cancer
BREMKE et al.
Anticancer Res 2009;29:2645-2653.
ABSTRACT
| FULL TEXT
Pretreatment Health Behaviors Predict Survival Among Patients With Head and Neck Squamous Cell Carcinoma
Duffy et al.
JCO 2009;27:1969-1975.
ABSTRACT
| FULL TEXT
Development of an Adenoviral Vaccine Against E6 and E7 Oncoproteins to Prevent Growth of Human Papillomavirus-Positive Cancer
Lee et al.
Arch Otolaryngol Head Neck Surg 2008;134:1316-1323.
ABSTRACT
| FULL TEXT
Chemoradiotherapy Laryngeal Preservation for Advanced Hypopharyngeal Cancer
Tai et al.
Jpn J Clin Oncol 2008;0:hyn073v1-7.
ABSTRACT
| FULL TEXT
CT Findings after Laryngectomy
Ferreiro-Arguelles et al.
RadioGraphics 2008;28:869-882.
ABSTRACT
| FULL TEXT
The PDZ Binding Motif of Human Papillomavirus Type 16 E6 Induces PTPN13 Loss, Which Allows Anchorage-Independent Growth and Synergizes with Ras for Invasive Growth
Spanos et al.
J. Virol. 2008;82:2493-2500.
ABSTRACT
| FULL TEXT
The Role of Human Papillomavirus 16 E6 in Anchorage-Independent and Invasive Growth of Mouse Tonsil Epithelium
Hoover et al.
Arch Otolaryngol Head Neck Surg 2007;133:495-502.
ABSTRACT
| FULL TEXT
Depressive Symptoms, Smoking, Drinking, and Quality of Life Among Head and Neck Cancer Patients
Duffy et al.
Psychosomatics 2007;48:142-148.
ABSTRACT
| FULL TEXT
Intensification regimen for advanced-stage resectable hypopharyngeal carcinoma.
Ozer et al.
Arch Otolaryngol Head Neck Surg 2006;132:385-389.
ABSTRACT
| FULL TEXT
Prognostic value of an activation state marker for epidermal growth factor receptor in tissue microarrays of head and neck cancer.
Kong et al.
Cancer Res. 2006;66:2834-2843.
ABSTRACT
| FULL TEXT
Overexpression of the Cytokine Osteopontin Identifies Aggressive Laryngeal Squamous Cell Carcinomas and Enhances Carcinoma Cell Proliferation and Invasiveness
Celetti et al.
Clin. Cancer Res. 2005;11:8019-8027.
ABSTRACT
| FULL TEXT
Defects in the Human Leukocyte Antigen Class I Antigen Processing Machinery in Head and Neck Squamous Cell Carcinoma: Association with Clinical Outcome
Meissner et al.
Clin. Cancer Res. 2005;11:2552-2560.
ABSTRACT
| FULL TEXT
Therapeutic Decision Making in Stages III and IV Head and Neck Squamous Cell Carcinoma
Gleich et al.
Arch Otolaryngol Head Neck Surg 2003;129:26-35.
ABSTRACT
| FULL TEXT
Human Papillomavirus Type 16 and Squamous Cell Carcinoma of the Head and Neck
Ringstrom et al.
Clin. Cancer Res. 2002;8:3187-3192.
ABSTRACT
| FULL TEXT
The Role of Intratumoral Therapy With Cisplatin/Epinephrine Injectable Gel in the Management of Advanced Squamous Cell Carcinoma of the Head and Neck
Wenig et al.
Arch Otolaryngol Head Neck Surg 2002;128:880-885.
ABSTRACT
| FULL TEXT
Dr Martin: How Are We Doing in 2000?: Hayes Martin Lecture
Byers
Arch Otolaryngol Head Neck Surg 2001;127:759-765.
FULL TEXT
High-Dose Intra-arterial Cisplatin Therapy Followed by Radiation Therapy for Advanced Squamous Cell Carcinoma of the Head and Neck
Wilson et al.
Arch Otolaryngol Head Neck Surg 2001;127:809-812.
ABSTRACT
| FULL TEXT
Treatment of Stage III and Stage IV Supraglottic Carcinoma: Should Elderly Patients Undergo Standard Treatment Protocols?
Knudsen
Arch Otolaryngol Head Neck Surg 1999;125:1406-1407.
FULL TEXT